경장 주사기 시장 : 유형별, 연령대별, 최종사용자별 - 세계 기회 분석 및 산업 예측(2024-2033년)

Enteral Syringe Market By Type (Reusable, Disposable), By Age Group (Adults, Pediatrics) By End User (Hospitals, Ambulatory Surgical Centers, Homecare) : Global Opportunity Analysis and Industry Forecast, 2024-2033

US $ 4,425 ￦ 6,219,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 7,412 ￦ 10,417,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

세계 경장 시린지 시장은 2023년 3억 8,360만 달러로 평가되며 2024년부터 2033년까지 연평균 5.3% 성장하여 2033년에는 6억 4,360만 달러에 달할 것으로 예상됩니다.

경장 시린지는 액체 약물, 영양제 또는 액체를 소화관에 직접 투여하는 데 사용되는 특수 의료기기로 일반적으로 영양 튜브를 통해 사용됩니다. 이 주사기는 정확한 용량 측정, 경장영양 튜브와의 호환성, 우발적 인 분리 및 누출을 방지하는 안전 메커니즘과 같은 기능으로 특별히 설계되었습니다.

경장 시린지 시장의 성장은 빈곤, 영양가 높은 식품에 대한 불충분 한 접근성, 만성 질환, 고령화 등이 영양 실조 발생률 증가에 기여하고 있습니다. 경장 시린지는 필요한 영양소를 소화관에 직접 공급하여 경구 섭취가 불충분하거나 불가능한 경우 환자가 충분한 영양을 섭취할 수 있도록 하는 중요한 역할을 합니다. 또한, 재택 의료에 대한 관심이 높아지면서 시장을 주도하고 있습니다. 병원에 입원하는 대신 집에서 경장 투약 및 영양 공급을 원하는 환자가 증가함에 따라 사용하기 쉬운 경장 시린지에 대한 수요가 증가하고 있습니다. 이에 따라 제조업체들은 사용하기 쉽고 가정용 장내 영양 공급 장치와 호환되는 주사기를 생산하고 있습니다.

그러나 엄격한 정부 규제가 시장 성장을 저해하는 요인으로 작용하고 있습니다. 규제 당국은 안전성, 유효성 및 품질을 보장하기 위해 경장 시린지를 포함한 의료기기에 엄격한 기준과 승인 절차를 적용하고 있습니다. 반면, 부작용이 적은 첨단 경장영양장치의 시장 개척은 시장 성장의 기회가 될 수 있습니다. 경장 시린지의 디자인, 재료 및 기능의 혁신은 환자의 편의성을 높이고 합병증을 줄이며 치료 결과를 개선하는 것을 목표로 하고 있습니다. 예를 들어, 박스터 인터내셔널(Baxter International Inc.)은 인체공학적 디자인, 정확한 용량 제어 메커니즘, 역류 방지 기능을 갖춘 경장 시린지를 개발하여 흡인 및 튜브 관련 합병증의 위험을 최소화하고 장내 영양 공급을 보다 안전하고 효율적으로 만들었습니다.

세분화의 개요

경장 시린지 시장은 유형, 연령대, 최종사용자, 지역으로 분류됩니다. 유형에 따라 시장은 재사용형과 일회용 유형으로 나뉩니다. 연령대별로는 성인과 소아로 나뉩니다. 최종사용자에 따라 병원, 외래 수술 센터(ASCS), 재택 의료로 분류됩니다. 지역별로는 북미, 유럽, 아시아태평양, LAMEA로 분석됩니다.

경쟁 시나리오

이 보고서는 사용자 정의가 가능합니다.

• 규제 가이드라인
• 고객의 관심사에 따른 기업 프로파일 추가
• 국가별 또는 지역별 추가 분석 - 시장 규모 및 전망
• 기업 개요 확장 목록
• 과거 시장 데이터
• 주요 기업의 세부 정보(위치, 연락처, 공급업체/벤더 네트워크 등 포함, 엑셀 형식)

목차

제1장 소개

제2장 주요 요약

제3장 시장 상황

• 시장 정의와 범위
• 주요 조사 결과
  • 주요 투자 기회
  • 주요 성공 전략
• Porter's Five Forces 분석
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회

제4장 경장 시린지 시장 : 유형별

• 시장 개요
• 재사용 가능
• 일회용

제5장 경장 시린지 시장 : 연령층별

• 시장 개요
• 성인
• 소아과

제6장 경장 시린지 시장 : 최종사용자별

• 시장 개요
• 병원
• 외래 수술 센터
• 재택의료

제7장 경장 시린지 시장 : 지역별

• 시장 개요
• 북미
  • 주요 시장 동향과 기회
  • 미국의 경장 시린지 시장
  • 캐나다의 경장 시린지 시장
  • 멕시코의 경장 시린지 시장
• 유럽
  • 주요 시장 동향과 기회
  • 독일의 경장 시린지 시장
  • 프랑스의 경장 시린지 시장
  • 영국의 경장 시린지 시장
  • 이탈리아의 경장 시린지 시장
  • 스페인의 경장 시린지 시장
  • 기타 유럽의 경장 시린지 시장
• 아시아태평양
  • 주요 시장 동향과 기회
  • 일본의 경장 시린지 시장
  • 중국의 경장 시린지 시장
  • 인도의 경장 시린지 시장
  • 호주의 경장 시린지 시장
  • 한국의 경장 시린지 시장
  • 기타 아시아태평양의 경장 시린지 시장
• 라틴아메리카, 중동 및 아프리카
  • 주요 시장 동향과 기회
  • 브라질의 경장 시린지 시장
  • 사우디아라비아의 경장 시린지 시장
  • 남아프리카공화국의 경장 시린지 시장
  • 기타 라틴아메리카, 중동 및 아프리카 경장 시린지 시장

제8장 경쟁 상황

• 소개
• 주요 성공 전략
• 주요 10개 기업 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2023년)

제9장 기업 개요

• Fresenius SE And Co. KGaA
• Boston Scientific Corporation
• Danone
• Cook Medical, Inc.
• Cardinal Health Inc.
• Becton, Dickinson And Company
• Moog Inc.
• B. Braun Melsungen AG
• Owens And Minor, Inc.
• Nestle S.A.

ksm

영문 목차

영문목차

The global enteral syringe market was valued at $383.6 million in 2023, and is projected to reach $643.6 million by 2033, growing at a CAGR of 5.3% from 2024 to 2033.

An enteral syringe is a specialized medical device used for administering liquid medications, nutrients, or fluids directly into the gastrointestinal tract, typically through a feeding tube. This syringe is specifically designed with features such as accurate volume measurement, compatibility with enteral feeding tubes, and safety mechanisms to prevent accidental disconnection or leakage.

The growth of the enteral syringe market is driven by poverty, inadequate access to nutritious food, chronic illnesses, and aging populations contribute to the rising incidence of malnutrition cases. Enteral syringes play a crucial role in delivering essential nutrients directly into the gastrointestinal tract, ensuring patients receive adequate nutrition when oral intake is insufficient or not feasible. Moreover, rise in the trend toward home healthcare is driving the market forward. With the rise in the number of patients seeking enteral medication and nutrition at home rather than admitted to hospitals, the demand for user-friendly enteral syringes is growing. Thus, manufacturers are producing syringes that are easy to use and set compatible with home enteral feeding equipment.

However, stringent governmental regulations pose a restraint to the growth of the market growth. Regulatory authorities impose strict standards and approval processes for medical devices, including enteral syringes, to ensure safety, efficacy, and quality. Contrarily, the development of advanced feeding devices with lesser side effects presents an opportunity for the growth of the market. Innovations in enteral syringe design, materials, and functionalities aim to enhance patient comfort, reduce complications, and improve treatment outcomes. For instance, the development of enteral syringes, by Baxter International Inc., with ergonomic designs, precise dosage control mechanisms, and anti-reflux features can minimize the risk of aspiration and tube-related complications, making enteral feeding safer and more efficient.

Segmentation Overview

The enteral syringe market is segmented into type, age group, end user, and region. Depending on the type, the market is bifurcated into reusable and disposable. According to age group, it is divided into adults and pediatrics. According to end user, the market is classified into hospitals, ambulatory surgical centers (ASCS), and home care. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Competitive Scenario

The major players operating in the enteral syringe market include Fresenius SE & Co. KGaA, Boston Scientific Corporation, Danone, Cook Medical, Inc., Cardinal Health Inc., Becton, Dickinson and Company, Moog Inc., B. Braun Melsungen AG, Owens & Minor, Inc., and Nestle S.A. Other players in the enteral syringe market include Medtronic PLC, Medline Industries LP, Kentec Medical Inc., Thermo Fisher Scientific Inc, and Baxter International Inc. These players have employed several strategies such as mergers & acquisitions, partnerships, collaboration, and continuous product development and innovation to strengthen their position in the competitive environment.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Type

• Reusable
• Disposable

By Age Group

• Adults
• Pediatrics

By End User

• Hospitals
• Ambulatory Surgical Centers
• Homecare

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• Fresenius SE & Co. KGaA
• Boston Scientific Corporation
• Danone
• Cook Medical, Inc.
• Cardinal Health Inc.
• Becton, Dickinson and Company
• Moog Inc.
• B. Braun Melsungen AG
• Owens & Minor, Inc.
• Nestle S.A.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report Description
• 1.2. Key Market Segments
• 1.3. Key Benefits
• 1.4. Research Methodology
  • 1.4.1. Primary Research
  • 1.4.2. Secondary Research
  • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

• 3.1. Market Definition and Scope
• 3.2. Key Findings
  • 3.2.1. Top Investment Pockets
  • 3.2.2. Top Winning Strategies
• 3.3. Porter's Five Forces Analysis
  • 3.3.1. Bargaining Power of Suppliers
  • 3.3.2. Threat of New Entrants
  • 3.3.3. Threat of Substitutes
  • 3.3.4. Competitive Rivalry
  • 3.3.5. Bargaining Power among Buyers
• 3.5. Market Dynamics
  • 3.5.1. Drivers
  • 3.5.2. Restraints
  • 3.5.3. Opportunities

CHAPTER 4: ENTERAL SYRINGE MARKET, BY TYPE

• 4.1. Market Overview
  • 4.1.1 Market Size and Forecast, By Type
• 4.2. Reusable
  • 4.2.1. Key Market Trends, Growth Factors and Opportunities
  • 4.2.2. Market Size and Forecast, By Region
  • 4.2.3. Market Share Analysis, By Country
• 4.3. Disposable
  • 4.3.1. Key Market Trends, Growth Factors and Opportunities
  • 4.3.2. Market Size and Forecast, By Region
  • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: ENTERAL SYRINGE MARKET, BY AGE GROUP

• 5.1. Market Overview
  • 5.1.1 Market Size and Forecast, By Age Group
• 5.2. Adults
  • 5.2.1. Key Market Trends, Growth Factors and Opportunities
  • 5.2.2. Market Size and Forecast, By Region
  • 5.2.3. Market Share Analysis, By Country
• 5.3. Pediatrics
  • 5.3.1. Key Market Trends, Growth Factors and Opportunities
  • 5.3.2. Market Size and Forecast, By Region
  • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: ENTERAL SYRINGE MARKET, BY END USER

• 6.1. Market Overview
  • 6.1.1 Market Size and Forecast, By End User
• 6.2. Hospitals
  • 6.2.1. Key Market Trends, Growth Factors and Opportunities
  • 6.2.2. Market Size and Forecast, By Region
  • 6.2.3. Market Share Analysis, By Country
• 6.3. Ambulatory Surgical Centers
  • 6.3.1. Key Market Trends, Growth Factors and Opportunities
  • 6.3.2. Market Size and Forecast, By Region
  • 6.3.3. Market Share Analysis, By Country
• 6.4. Homecare
  • 6.4.1. Key Market Trends, Growth Factors and Opportunities
  • 6.4.2. Market Size and Forecast, By Region
  • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: ENTERAL SYRINGE MARKET, BY REGION

• 7.1. Market Overview
  • 7.1.1 Market Size and Forecast, By Region
• 7.2. North America
  • 7.2.1. Key Market Trends and Opportunities
  • 7.2.2. Market Size and Forecast, By Type
  • 7.2.3. Market Size and Forecast, By Age Group
  • 7.2.4. Market Size and Forecast, By End User
  • 7.2.5. Market Size and Forecast, By Country
  • 7.2.6. U.S. Enteral Syringe Market
    • 7.2.6.1. Market Size and Forecast, By Type
    • 7.2.6.2. Market Size and Forecast, By Age Group
    • 7.2.6.3. Market Size and Forecast, By End User
  • 7.2.7. Canada Enteral Syringe Market
    • 7.2.7.1. Market Size and Forecast, By Type
    • 7.2.7.2. Market Size and Forecast, By Age Group
    • 7.2.7.3. Market Size and Forecast, By End User
  • 7.2.8. Mexico Enteral Syringe Market
    • 7.2.8.1. Market Size and Forecast, By Type
    • 7.2.8.2. Market Size and Forecast, By Age Group
    • 7.2.8.3. Market Size and Forecast, By End User
• 7.3. Europe
  • 7.3.1. Key Market Trends and Opportunities
  • 7.3.2. Market Size and Forecast, By Type
  • 7.3.3. Market Size and Forecast, By Age Group
  • 7.3.4. Market Size and Forecast, By End User
  • 7.3.5. Market Size and Forecast, By Country
  • 7.3.6. Germany Enteral Syringe Market
    • 7.3.6.1. Market Size and Forecast, By Type
    • 7.3.6.2. Market Size and Forecast, By Age Group
    • 7.3.6.3. Market Size and Forecast, By End User
  • 7.3.7. France Enteral Syringe Market
    • 7.3.7.1. Market Size and Forecast, By Type
    • 7.3.7.2. Market Size and Forecast, By Age Group
    • 7.3.7.3. Market Size and Forecast, By End User
  • 7.3.8. UK Enteral Syringe Market
    • 7.3.8.1. Market Size and Forecast, By Type
    • 7.3.8.2. Market Size and Forecast, By Age Group
    • 7.3.8.3. Market Size and Forecast, By End User
  • 7.3.9. Italy Enteral Syringe Market
    • 7.3.9.1. Market Size and Forecast, By Type
    • 7.3.9.2. Market Size and Forecast, By Age Group
    • 7.3.9.3. Market Size and Forecast, By End User
  • 7.3.10. Spain Enteral Syringe Market
    • 7.3.10.1. Market Size and Forecast, By Type
    • 7.3.10.2. Market Size and Forecast, By Age Group
    • 7.3.10.3. Market Size and Forecast, By End User
  • 7.3.11. Rest of Europe Enteral Syringe Market
    • 7.3.11.1. Market Size and Forecast, By Type
    • 7.3.11.2. Market Size and Forecast, By Age Group
    • 7.3.11.3. Market Size and Forecast, By End User
• 7.4. Asia-Pacific
  • 7.4.1. Key Market Trends and Opportunities
  • 7.4.2. Market Size and Forecast, By Type
  • 7.4.3. Market Size and Forecast, By Age Group
  • 7.4.4. Market Size and Forecast, By End User
  • 7.4.5. Market Size and Forecast, By Country
  • 7.4.6. Japan Enteral Syringe Market
    • 7.4.6.1. Market Size and Forecast, By Type
    • 7.4.6.2. Market Size and Forecast, By Age Group
    • 7.4.6.3. Market Size and Forecast, By End User
  • 7.4.7. China Enteral Syringe Market
    • 7.4.7.1. Market Size and Forecast, By Type
    • 7.4.7.2. Market Size and Forecast, By Age Group
    • 7.4.7.3. Market Size and Forecast, By End User
  • 7.4.8. India Enteral Syringe Market
    • 7.4.8.1. Market Size and Forecast, By Type
    • 7.4.8.2. Market Size and Forecast, By Age Group
    • 7.4.8.3. Market Size and Forecast, By End User
  • 7.4.9. Australia Enteral Syringe Market
    • 7.4.9.1. Market Size and Forecast, By Type
    • 7.4.9.2. Market Size and Forecast, By Age Group
    • 7.4.9.3. Market Size and Forecast, By End User
  • 7.4.10. South Korea Enteral Syringe Market
    • 7.4.10.1. Market Size and Forecast, By Type
    • 7.4.10.2. Market Size and Forecast, By Age Group
    • 7.4.10.3. Market Size and Forecast, By End User
  • 7.4.11. Rest of Asia-Pacific Enteral Syringe Market
    • 7.4.11.1. Market Size and Forecast, By Type
    • 7.4.11.2. Market Size and Forecast, By Age Group
    • 7.4.11.3. Market Size and Forecast, By End User
• 7.5. LAMEA
  • 7.5.1. Key Market Trends and Opportunities
  • 7.5.2. Market Size and Forecast, By Type
  • 7.5.3. Market Size and Forecast, By Age Group
  • 7.5.4. Market Size and Forecast, By End User
  • 7.5.5. Market Size and Forecast, By Country
  • 7.5.6. Brazil Enteral Syringe Market
    • 7.5.6.1. Market Size and Forecast, By Type
    • 7.5.6.2. Market Size and Forecast, By Age Group
    • 7.5.6.3. Market Size and Forecast, By End User
  • 7.5.7. Saudi Arabia Enteral Syringe Market
    • 7.5.7.1. Market Size and Forecast, By Type
    • 7.5.7.2. Market Size and Forecast, By Age Group
    • 7.5.7.3. Market Size and Forecast, By End User
  • 7.5.8. South Africa Enteral Syringe Market
    • 7.5.8.1. Market Size and Forecast, By Type
    • 7.5.8.2. Market Size and Forecast, By Age Group
    • 7.5.8.3. Market Size and Forecast, By End User
  • 7.5.9. Rest of LAMEA Enteral Syringe Market
    • 7.5.9.1. Market Size and Forecast, By Type
    • 7.5.9.2. Market Size and Forecast, By Age Group
    • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top Winning Strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

• 9.1. Fresenius SE And Co. KGaA
  • 9.1.1. Company Overview
  • 9.1.2. Key Executives
  • 9.1.3. Company Snapshot
  • 9.1.4. Operating Business Segments
  • 9.1.5. Product Portfolio
  • 9.1.6. Business Performance
  • 9.1.7. Key Strategic Moves and Developments
• 9.2. Boston Scientific Corporation
  • 9.2.1. Company Overview
  • 9.2.2. Key Executives
  • 9.2.3. Company Snapshot
  • 9.2.4. Operating Business Segments
  • 9.2.5. Product Portfolio
  • 9.2.6. Business Performance
  • 9.2.7. Key Strategic Moves and Developments
• 9.3. Danone
  • 9.3.1. Company Overview
  • 9.3.2. Key Executives
  • 9.3.3. Company Snapshot
  • 9.3.4. Operating Business Segments
  • 9.3.5. Product Portfolio
  • 9.3.6. Business Performance
  • 9.3.7. Key Strategic Moves and Developments
• 9.4. Cook Medical, Inc.
  • 9.4.1. Company Overview
  • 9.4.2. Key Executives
  • 9.4.3. Company Snapshot
  • 9.4.4. Operating Business Segments
  • 9.4.5. Product Portfolio
  • 9.4.6. Business Performance
  • 9.4.7. Key Strategic Moves and Developments
• 9.5. Cardinal Health Inc.
  • 9.5.1. Company Overview
  • 9.5.2. Key Executives
  • 9.5.3. Company Snapshot
  • 9.5.4. Operating Business Segments
  • 9.5.5. Product Portfolio
  • 9.5.6. Business Performance
  • 9.5.7. Key Strategic Moves and Developments
• 9.6. Becton, Dickinson And Company
  • 9.6.1. Company Overview
  • 9.6.2. Key Executives
  • 9.6.3. Company Snapshot
  • 9.6.4. Operating Business Segments
  • 9.6.5. Product Portfolio
  • 9.6.6. Business Performance
  • 9.6.7. Key Strategic Moves and Developments
• 9.7. Moog Inc.
  • 9.7.1. Company Overview
  • 9.7.2. Key Executives
  • 9.7.3. Company Snapshot
  • 9.7.4. Operating Business Segments
  • 9.7.5. Product Portfolio
  • 9.7.6. Business Performance
  • 9.7.7. Key Strategic Moves and Developments
• 9.8. B. Braun Melsungen AG
  • 9.8.1. Company Overview
  • 9.8.2. Key Executives
  • 9.8.3. Company Snapshot
  • 9.8.4. Operating Business Segments
  • 9.8.5. Product Portfolio
  • 9.8.6. Business Performance
  • 9.8.7. Key Strategic Moves and Developments
• 9.9. Owens And Minor, Inc.
  • 9.9.1. Company Overview
  • 9.9.2. Key Executives
  • 9.9.3. Company Snapshot
  • 9.9.4. Operating Business Segments
  • 9.9.5. Product Portfolio
  • 9.9.6. Business Performance
  • 9.9.7. Key Strategic Moves and Developments
• 9.10. Nestle S.A.
  • 9.10.1. Company Overview
  • 9.10.2. Key Executives
  • 9.10.3. Company Snapshot
  • 9.10.4. Operating Business Segments
  • 9.10.5. Product Portfolio
  • 9.10.6. Business Performance
  • 9.10.7. Key Strategic Moves and Developments

관련자료